MPI 5003
Alternative Names: AccuSite; Fluorouracil/epinephrine injectable gelLatest Information Update: 24 Oct 2021
At a glance
- Originator Chiron Corporation
- Developer ALTANA Group; Chiron Corporation; Dompe; Savage Laboratories
- Class
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Human papillomavirus infections
- Discontinued Basal cell cancer; Kaposi's sarcoma; Psoriasis; Squamous cell cancer
Most Recent Events
- 24 Jun 1999 Discontinued-II for Kaposi's sarcoma in United Kingdom (Intralesional)
- 24 Jun 1999 Discontinued-II for Squamous cell cancer in Australia (Intralesional)
- 24 Jun 1999 Discontinued-II for Squamous cell cancer in USA (Intralesional)